Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ding

Showing results (481-490 of 535) with videos related to

Pageof 54
Sort By:
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Scientific Reports|December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorM Giel-Moloney, M Esteban, B H Oakes, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2024
Perianal Fistulizing Crohn's Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized CareLuke N Hanna, Sulak Anandabaskaran, Nusrat Iqbal, et al.
Physical Review Letters|September 22, 2023
Measurement of the Prompt D^{0} Nuclear Modification Factor in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|August 25, 2023
Evidence for Modification of b Quark Hadronization in High-Multiplicity pp Collisions at sqrt[s]=13  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|August 11, 2023
Nuclear Modification Factor of Neutral Pions in the Forward and Backward Regions in p-Pb CollisionsR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|March 8, 2024
Observation of Cabibbo-Suppressed Two-Body Hadronic Decays and Precision Mass Measurement of the Ω_{c}^{0} BaryonR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|October 28, 2023
Measurement of the Λ_{b}^{0}→Λ(1520)μ^{+}μ^{-} Differential Branching FractionR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Pageof 54

Showing results (481-490 of 535) with videos related to

Sort By:
Pageof 54
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Scientific Reports|December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorM Giel-Moloney, M Esteban, B H Oakes, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2024
Perianal Fistulizing Crohn's Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized CareLuke N Hanna, Sulak Anandabaskaran, Nusrat Iqbal, et al.
Physical Review Letters|September 22, 2023
Measurement of the Prompt D^{0} Nuclear Modification Factor in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|August 25, 2023
Evidence for Modification of b Quark Hadronization in High-Multiplicity pp Collisions at sqrt[s]=13  TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|August 11, 2023
Nuclear Modification Factor of Neutral Pions in the Forward and Backward Regions in p-Pb CollisionsR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|March 8, 2024
Observation of Cabibbo-Suppressed Two-Body Hadronic Decays and Precision Mass Measurement of the Ω_{c}^{0} BaryonR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|October 28, 2023
Measurement of the Λ_{b}^{0}→Λ(1520)μ^{+}μ^{-} Differential Branching FractionR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Pageof 54